Dr. Roberto De Luca will give a talk entitled “Tripokin: Best-in-Class potential for tumor targeted Interleukin-2 (IL2) potentiated by Tumor Necrosis Factor (TNF)” (16th of November, 08:30 pm local time).

Follow the link for more details.